BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 12652618)

  • 1. Expression of the lipogenic enzyme fatty acid synthase (FAS) as a predictor of poor outcome in nephroblastoma: an interinstitutional study.
    Camassei FD; Jenkner A; Ravà L; Bosman C; Francalanci P; Donfrancesco A; Alò PL; Boldrini R
    Med Pediatr Oncol; 2003 May; 40(5):302-8. PubMed ID: 12652618
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fatty acid synthase over expression is an indicator of tumor aggressiveness and poor prognosis in renal cell carcinoma.
    Horiguchi A; Asano T; Asano T; Ito K; Sumitomo M; Hayakawa M
    J Urol; 2008 Sep; 180(3):1137-40. PubMed ID: 18639282
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of fatty acid synthase (FAS) as a predictor of recurrence in stage I breast carcinoma patients.
    Alo' PL; Visca P; Marci A; Mangoni A; Botti C; Di Tondo U
    Cancer; 1996 Feb; 77(3):474-82. PubMed ID: 8630954
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of fatty acid synthase as a prognostic indicator in soft tissue sarcomas.
    Takahiro T; Shinichi K; Toshimitsu S
    Clin Cancer Res; 2003 Jun; 9(6):2204-12. PubMed ID: 12796387
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic value of p53 expression in Wilms' tumor in children.
    Skotnicka-Klonowicz G; Kobos J; Łoś E; Trejster E; Szymik-Kontorowicz S; Daszkiewicz P
    Med Sci Monit; 2001; 7(6):1224-9. PubMed ID: 11687734
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The expression of fatty acid synthase (FASE) is an early event in the development and progression of squamous cell carcinoma of the lung.
    Piyathilake CJ; Frost AR; Manne U; Bell WC; Weiss H; Heimburger DC; Grizzle WE
    Hum Pathol; 2000 Sep; 31(9):1068-73. PubMed ID: 11014573
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Minichromosome maintenance 2 (MCM2) is a new prognostic proliferative marker in Wilms tumour.
    Taran K; Sitkiewicz A; Andrzejewska E; Kobos J
    Pol J Pathol; 2011; 62(2):84-8. PubMed ID: 21866463
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased tissue factor expression and poor nephroblastoma prognosis.
    Maciel EO; Carvalhal GF; da Silva VD; Batista EL; Garicochea B
    J Urol; 2009 Oct; 182(4):1594-9. PubMed ID: 19683742
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Results of the SIOP 93-01/GPOH trial and study for the treatment of patients with unilateral nonmetastatic Wilms Tumor.
    Reinhard H; Semler O; Bürger D; Bode U; Flentje M; Göbel U; Gutjahr P; Leuschner I; Maass E; Niggli F; Scheel-Walter HG; Stöckle M; Thüroff JW; Tröger J; Weirich A; von Schweinitz D; Zoubek A; Graf N
    Klin Padiatr; 2004; 216(3):132-40. PubMed ID: 15175957
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High prevalence of fatty acid synthase expression in colorectal cancers in Middle Eastern patients and its potential role as a therapeutic target.
    Uddin S; Hussain AR; Ahmed M; Abubaker J; Al-Sanea N; Abduljabbar A; Ashari LH; Alhomoud S; Al-Dayel F; Bavi P; Al-Kuraya KS
    Am J Gastroenterol; 2009 Jul; 104(7):1790-801. PubMed ID: 19491830
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nephroblastoma: multidrug-resistance P-glycoprotein expression in tumor cells and intratumoral capillary endothelial cells.
    Camassei FD; Arancia G; Cianfriglia M; Bosman C; Francalanci P; Ravà L; Jenkner A; Donfrancesco A; Boldrini R
    Am J Clin Pathol; 2002 Mar; 117(3):484-90. PubMed ID: 11888090
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB.
    Menendez JA; Mehmi I; Atlas E; Colomer R; Lupu R
    Int J Oncol; 2004 Mar; 24(3):591-608. PubMed ID: 14767544
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential expression of the heat shock protein 70 in the histological compartments of nephroblastomas.
    Efferth T; Schulten HG; Thelen P; Bode ME; Beniers AJ; Granzen B; Ringert RH; Mertens R; Gefeller O; Jakse G; Fuzesi L
    Anticancer Res; 2001; 21(4B):2915-20. PubMed ID: 11712786
    [TBL] [Abstract][Full Text] [Related]  

  • 14. C-kit protein expression in Wilms' tumour: an immunohistochemical study.
    Giordano G; Campanini N; Rocco A; Donofrio V; Bertolini P; Falleti J; Pettinato G
    Eur J Surg Oncol; 2009 Jun; 35(6):629-35. PubMed ID: 19010635
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression and prognostic value Of CD44 isoforms in nephroblastoma (Wilms tumor).
    Ghanem MA; Van Steenbrugge GJ; Van Der Kwast TH; Sudaryo MK; Noordzij MA; Nijman RJ
    J Urol; 2002 Aug; 168(2):681-6. PubMed ID: 12131349
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunohistochemical detection of p53 protein expression as a prognostic factor in Wilms tumor.
    Jadali F; Sayadpour D; Rakhshan M; Karimi A; Rouzrokh M; Shamsian BS; Shamshiri AR
    Iran J Kidney Dis; 2011 Jul; 5(3):149-53. PubMed ID: 21525573
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overexpression and hyperactivity of breast cancer-associated fatty acid synthase (oncogenic antigen-519) is insensitive to normal arachidonic fatty acid-induced suppression in lipogenic tissues but it is selectively inhibited by tumoricidal alpha-linolenic and gamma-linolenic fatty acids: a novel mechanism by which dietary fat can alter mammary tumorigenesis.
    Menendez JA; Ropero S; Mehmi I; Atlas E; Colomer R; Lupu R
    Int J Oncol; 2004 Jun; 24(6):1369-83. PubMed ID: 15138577
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictive role of thymidylate synthase, dihydropyrimidine dehydrogenase and thymidine phosphorylase expression in colorectal cancer patients receiving adjuvant 5-fluorouracil.
    Ciaparrone M; Quirino M; Schinzari G; Zannoni G; Corsi DC; Vecchio FM; Cassano A; La Torre G; Barone C
    Oncology; 2006; 70(5):366-77. PubMed ID: 17179731
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of fatty acid synthase, ErbB2 and Ki-67 in head and neck squamous cell carcinoma. A clinicopathological study.
    Silva SD; Agostini M; Nishimoto IN; Coletta RD; Alves FA; Lopes MA; Kowalski LP; Graner E
    Oral Oncol; 2004 Aug; 40(7):688-96. PubMed ID: 15172638
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fatty acid synthase expression defines distinct molecular signatures in prostate cancer.
    Rossi S; Graner E; Febbo P; Weinstein L; Bhattacharya N; Onody T; Bubley G; Balk S; Loda M
    Mol Cancer Res; 2003 Aug; 1(10):707-15. PubMed ID: 12939396
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.